Xu Li
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy Sepsis, Sepsis-induced Coagulopathy, Nafamostat Mesilate | Phase 4 | 2023-10-01 |